CDKN2A and melanoma: Atypical nevi also act as independent risk markers overall, regardless of family history and pathogenic mutation status; however, unlike common melanocytic nevi, atypical nevi contribute to the development of melanoma synergistically with the CDKN2A-mutation carriage, as represented in the FAMMM syndrome [11].